BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
33.395 EUR
-0.23 (-0.68%)
We assign a fundamental rating of 3 out of 10 to BAYN. BAYN was compared to 54 industry peers in the Pharmaceuticals industry. BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. BAYN has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
BAYN had positive earnings in the past year.
In the past year BAYN had a positive cash flow from operations.
In multiple years BAYN reported negative net income over the last 5 years.
Each year in the past 5 years BAYN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BAYN (-0.19%) is worse than 61.82% of its industry peers.
The Return On Equity of BAYN (-0.67%) is worse than 61.82% of its industry peers.
BAYN has a Return On Invested Capital of 1.80%. This is in the lower half of the industry: BAYN underperforms 65.45% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BAYN is significantly below the industry average of 13.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROIC | 1.8% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
1.3 Margins
The Operating Margin of BAYN (4.20%) is worse than 63.64% of its industry peers.
BAYN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 56.35%, BAYN is doing worse than 69.09% of the companies in the same industry.
BAYN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
BAYN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BAYN has about the same amount of shares outstanding.
Compared to 5 years ago, BAYN has about the same amount of shares outstanding.
BAYN has a better debt/assets ratio than last year.
2.2 Solvency
BAYN has an Altman-Z score of 0.93. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
BAYN's Altman-Z score of 0.93 is on the low side compared to the rest of the industry. BAYN is outperformed by 74.55% of its industry peers.
The Debt to FCF ratio of BAYN is 10.07, which is on the high side as it means it would take BAYN, 10.07 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 10.07, BAYN is not doing good in the industry: 69.09% of the companies in the same industry are doing better.
BAYN has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BAYN (1.11) is worse than 67.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 0.93 |
ROIC/WACC0.28
WACC6.4%
2.3 Liquidity
A Current Ratio of 1.14 indicates that BAYN should not have too much problems paying its short term obligations.
The Current ratio of BAYN (1.14) is worse than 70.91% of its industry peers.
BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.71, BAYN is not doing good in the industry: 78.18% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
Looking at the last year, BAYN shows a decrease in Revenue. The Revenue has decreased by -1.87% in the last year.
Measured over the past years, BAYN shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
The Earnings Per Share is expected to grow by 3.48% on average over the next years.
BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.44% yearly.
EPS Next Y-5.62%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
EPS Next 5Y3.48%
Revenue Next Year-1.51%
Revenue Next 2Y-0.28%
Revenue Next 3Y0.53%
Revenue Next 5Y1.44%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 6.25, which indicates a rather cheap valuation of BAYN.
BAYN's Price/Earnings ratio is rather cheap when compared to the industry. BAYN is cheaper than 98.18% of the companies in the same industry.
BAYN is valuated cheaply when we compare the Price/Earnings ratio to 26.49, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 6.86, which indicates a rather cheap valuation of BAYN.
Based on the Price/Forward Earnings ratio, BAYN is valued cheaper than 94.55% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BAYN to the average of the S&P500 Index (23.69), we can say BAYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.25 | ||
| Fwd PE | 6.86 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BAYN is valued a bit cheaper than the industry average as 65.45% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BAYN is valued cheaply inside the industry as 89.09% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.34 | ||
| EV/EBITDA | 10.39 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
5. Dividend
5.1 Amount
With a yearly dividend of 0.33%, BAYN is not a good candidate for dividend investing.
BAYN's Dividend Yield is slightly below the industry average, which is at 2.90.
With a Dividend Yield of 0.33, BAYN pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-65.15%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
FRA:BAYN (12/5/2025, 7:00:00 PM)
33.395
-0.23 (-0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.81B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts71.43
Price Target32.59 (-2.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)12.1%
PT rev (3m)12%
EPS NQ rev (1m)-37.31%
EPS NQ rev (3m)-37.41%
EPS NY rev (1m)0.93%
EPS NY rev (3m)0.91%
Revenue NQ rev (1m)-2.04%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.25 | ||
| Fwd PE | 6.86 | ||
| P/S | 0.72 | ||
| P/FCF | 8.34 | ||
| P/OCF | 4.88 | ||
| P/B | 1.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.39 |
EPS(TTM)5.34
EY15.99%
EPS(NY)4.87
Fwd EY14.57%
FCF(TTM)4.01
FCFY11.99%
OCF(TTM)6.84
OCFY20.49%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROCE | 2.56% | ||
| ROIC | 1.8% | ||
| ROICexc | 2% | ||
| ROICexgc | 6.8% | ||
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM | 8.58% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 5.32 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 1.09 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.93 |
F-Score5
WACC6.4%
ROIC/WACC0.28
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.62%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
EPS Next 5Y3.48%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.51%
Revenue Next 2Y-0.28%
Revenue Next 3Y0.53%
Revenue Next 5Y1.44%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.17%
EBIT Next 3Y21.41%
EBIT Next 5Y11.27%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status for BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for BAYN stock?
The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -5.62% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.